FANCA and Friedreich ataxia: In conclusion, application of NGS-based gene panel testing for all known FA genes in combination with chromosomal microarrays for FANCA or, as a new option—copy number variant (CNV) testing with NGS, provides a comprehensive approach for mutational FANCA screening, including identification of large deletions, and should be offered to all clinically diagnosed FA patients.